Medicare Enrolled
Dr. Jeffrey Guttas, M.D.
Cardiovascular Disease · San Mateo, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Guttas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guttas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Guttas
Dr. Jeffrey Guttas is a cardiovascular disease specialist in San Mateo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Guttas performed 2,378 Medicare services across 1,792 unique beneficiaries.
Between the years covered by Open Payments, Dr. Guttas received a total of $24,626 from 45 pharmaceutical and/or device companies across 1052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guttas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 43% volume in CA
$24,626 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,378
Medicare services
Top 43% in CA for cardiovascular disease
1,792
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~125 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,208 | $108 | $323 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
216 | $13 | $53 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
147 | $138 | $488 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
131 | $7 | $25 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
120 | $195 | $637 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
119 | $73 | $221 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
83 | $162 | $432 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
54 | $29 | $99 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
52 | $185 | $750 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
51 | $19 | $64 |
| Continuous external EKG monitoring, 8-15 days Continuous external electrocardiogram monitoring over a period of 8 to 15 days, including analysis and reporting of heart rhythm. |
32 | $268 | $500 |
| Stress echocardiogram An ultrasound of the heart performed while at rest and during exercise or drug-induced stress to evaluate heart function under different conditions. |
29 | $62 | $206 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
26 | $19 | $64 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
26 | $13 | $42 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
24 | $91 | $324 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
23 | $182 | $636 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $72 | $206 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $157 | $576 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
12.9% medium
84.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,626
Total received (2018-2024)
Avg $3,518/year across 7 years
Top 15% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
1,052
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,141 (85.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,485 (14.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,557
2023
$6,482
2022
$3,306
2021
$2,781
2020
$1,466
2019
$3,385
2018
$3,649
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$363
AstraZeneca Pharmaceuticals LP
$324
Novo Nordisk Inc
$322
PFIZER INC.
$285
Novartis Pharmaceuticals Corporation
$261
E.R. Squibb & Sons, L.L.C.
$261
Kiniksa Pharmaceuticals International, plc
$250
Esperion Therapeutics, Inc.
$215
Boston Scientific Corporation
$214
Boehringer Ingelheim Pharmaceuticals, Inc.
$200
Chiesi USA, Inc.
$194
Edwards Lifesciences Corporation
$161
Janssen Pharmaceuticals, Inc
$139
Bayer Healthcare Pharmaceuticals Inc.
$79
Philips North America LLC
$72
Merck Sharp & Dohme LLC
$68
Lexicon Pharmaceuticals, Inc.
$68
ATRICURE, INC.
$30
Medtronic, Inc.
$28
Actelion Pharmaceuticals US, Inc.
$25
Top 3 companies account for 28.4% of 2024 payments
All-time payments by company (2018-2024) ›
Caption Health, Inc.
$3,250
Janssen Pharmaceuticals, Inc
$2,331
Amgen Inc.
$2,145
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,635
AstraZeneca Pharmaceuticals LP
$1,538
Novartis Pharmaceuticals Corporation
$1,535
E.R. Squibb & Sons, L.L.C.
$1,441
Chiesi USA, Inc.
$1,161
PFIZER INC.
$1,054
Esperion Therapeutics, Inc.
$1,023
Novo Nordisk Inc
$969
Allergan Inc.
$672
Kowa Pharmaceuticals America, Inc.
$572
Merck Sharp & Dohme LLC
$490
SANOFI-AVENTIS U.S. LLC
$435
Regeneron Healthcare Solutions, Inc.
$408
Boston Scientific Corporation
$381
Amarin Pharma Inc.
$332
Edwards Lifesciences Corporation
$284
Bayer Healthcare Pharmaceuticals Inc.
$275
Bayer HealthCare Pharmaceuticals Inc.
$260
Gilead Sciences, Inc.
$257
Kiniksa Pharmaceuticals International, plc
$250
BOSTON SCIENTIFIC CORPORATION
$213
CHIESI USA, INC.
$176
Kiniksa Pharmaceuticals, Ltd.
$147
Lexicon Pharmaceuticals, Inc.
$145
Medtronic Vascular, Inc.
$142
Lundbeck LLC
$138
BIOTRONIK INC.
$119
Philips Electronics North America Corporation
$115
Actelion Pharmaceuticals US, Inc.
$115
Merck Sharp & Dohme Corporation
$107
Relypsa, Inc.
$102
Medtronic, Inc.
$75
Philips North America LLC
$72
Alnylam Pharmaceuticals Inc.
$53
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$50
AtriCure, Inc.
$31
ATRICURE, INC.
$30
Abbott Laboratories
$24
Preventice Services, LLC
$22
Arbor Pharmaceuticals, Inc.
$18
HeartFlow, Inc.
$17
CMP Pharma, Inc.
$16
Top 3 companies account for 31.4% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ATRICLIP LAA EXCLUSION SYSTEM · Adempas · Arcalyst · Azure · BRILINTA · BYSTOLIC · CAMZYOS · CAROSPIR · CHANTIX · CLEVIPREX · CLEVIPREX 50MG/100ML · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · Caption Interpretation AutoEF · Claria MRI · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMPLICITI · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · Inpefa · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LifeVest · Livalo · MULTAQ · Merlin Connectivity and Remote · Micra · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Orsiro · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RYBELSUS · Repatha · Reveal LINQ · Rybelsus · SAPIEN 3 Ultra RESILIA · VERQUVO · VRAYLAR · VYNDAQEL · Vascepa · Veltassa · WAINUA · WATCHMAN · WATCHMAN FLX · WINREVAIR · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
307
Per 100K population
41.2
County median income
$156,000
Nearest hospital
SAN MATEO MEDICAL CENTER
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Guttas is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 15% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Guttas experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Guttas performed 1,208 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Guttas receive payments from pharmaceutical companies?
Yes. Dr. Guttas received a total of $24,626 from 45 companies across 1,052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guttas's costs compare to other cardiologists in San Mateo?
Dr. Guttas's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guttas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Mateo
Browse cardiologists in San Mateo ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Caption Health, Inc. Payments to Doctors
See all physicians who received payments from Caption Health, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology